Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Vesicure Announces Positive Early Results of Exosome Technology for siRNA Delivery

publication date: Jan 29, 2024

Suzhou Vesicure Therapeutics, a company developing exosomes to deliver siRNA drugs, announced that its extracellular vesicles (EVs) successfully carried siRNA cargo targeting a KRAS mutation in a CDX (Cell line-derived xenograft) mouse tumor model. EVs are endogenous, cell secreted nano-vehicles that Vesicure believes have potential to offer safer delivery of regenerative therapies than cell therapies. In a new study, Vesicure applied its exosome-siRNA technology to target a KRAS mutation in a CDX mouse model. The IV injected exosomes were enriched in tumors, inhibiting growth without causing significant toxicity in the mice models. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here